BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of cefpodoxime in respiratory tract infections]. 1993

H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus.

Cefpodoxime (CPDX-PR) was evaluated clinically in respiratory tract infections. The results obtained are summarized as follows; 1. The total number of the patients who were treated with CPDX-PR was 61, out of whom 53 cases were evaluated for clinical efficacy and 55 cases were investigated for the safety of the drug. CPDX-PR was given orally twice a day at 100-200 mg for 5-21 days. 2. Clinical efficacies were excellent in 9 patients, good in 36, fair in 4 and poor in 4. The overall clinical efficacy was 84.9%. In particular, CPDX-PR showed satisfactory efficacy for acute respiratory infections and mild chronic respiratory infections, with efficacy rates of 88.6% (31/35) and 100% (8/8), respectively. 3. No adverse reactions was observed, but slight and transient elevation of BUN was noted. In conclusion, it has been confirmed that CPDX-PR is an excellent and safe drug for the treatment of the respiratory tract infections.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097627 Cefpodoxime Proxetil A prodrug of its active metabolite CEFPODOXIME. 1-(Isopropoxycarbonyloxy)ethyl-7-(2-(2-Amino-4-thiazolyl)-2-(Methoxyimino)Acetamido)-3-Methoxymethyl-8-oxo-5-thia-1-Azabicyclo(4,2,0)-oct-2-ene-2-Carboxylate,Cephalosporin 807,Orelox,Otreon,U-76252,CS 807,CS-807,U 76252,Vantin,76252, U,807, CS,807, Cephalosporin,Proxetil, Cefpodoxime,U76252
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
[Clinical studies of cefpodoxime proxetil in respiratory tract infections].
October 1988, The Japanese journal of antibiotics,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
Cefpodoxime proxetil in upper respiratory tract infections.
January 1991, Drugs,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
Comparative evaluation of cefpodoxime versus cefixime in children with lower respiratory tract infections.
June 2004, Indian journal of pediatrics,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
Cefpodoxime - utility in respiratory tract infections and typhoid fever.
May 2004, Indian journal of pediatrics,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
Clinical efficacy of cefpodoxime in respiratory tract infection.
July 2002, The Journal of antimicrobial chemotherapy,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
January 1991, Drugs,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
[Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
January 1994, The Japanese journal of antibiotics,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
Once-a-day therapy of cefpodoxime proxetil for respiratory tract infections.
November 1995, Journal of chemotherapy (Florence, Italy),
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
[Clinical evaluation of cefoxitin in respiratory tract infections].
May 1983, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Fukuhara, and Y Irabu, and T Kakazu, and H Nakamura, and Y Shigeno, and A Saito, and T Owan, and H Oshiro, and T Miyaguni, and K Nakasone
[Clinical evaluation of cefteram pivoxil in respiratory tract infections].
February 1990, The Japanese journal of antibiotics,
Copied contents to your clipboard!